Search papers, labs, and topics across Lattice.
This study introduces Progressive Experience Fusion (PEF) to enhance a multi-task TD-MPC2 controller for autonomous endovascular navigation, addressing the challenge of navigating complex vascular anatomies. The PEF approach significantly outperformed traditional methods, achieving a mean success rate of 74% across five subtasks compared to 37% for Soft Actor-Critic and 65% for base TD-MPC2, with an adaptive-horizon planning variant reaching 90% success in patient-specific simulations. Additionally, the PEF controller demonstrated effective transferability to an unseen in vitro stroke patient vasculature, improving path ratio from 63% to 80% after fine-tuning, highlighting its potential for real-world clinical applications.
PEF not only boosts navigation success rates in complex vascular environments but also adapts seamlessly to patient-specific anatomies, paving the way for improved clinical outcomes.
Autonomous endovascular navigation could support the delivery of mechanical thrombectomy to underserved areas, but controllers must navigate long, multi-stage paths across varying vascular anatomies. This study investigates Progressive Experience Fusion (PEF) to train a multi-task TD-MPC2 controller. We additionally evaluate a heuristic that changes the Model Predictive Path Integral planning horizon using residual action-sequence dispersion, and fine-tuning in a patient-specific simulation. Across five subtasks in ten known training anatomies with held-out targets, PEF achieved a mean success rate of 74%, compared with 37% for Soft Actor-Critic (p<0.001) and 65% for base TD-MPC2 (p = 0.053). A PEF controller with adaptive-horizon planning trained on 30 vasculatures achieved a mean success rate of 90% in ten held-out vasculatures. The PEF agent successfully transferred to an unseen in vitro stroke patient vasculature under fluoroscopy, achieving a mean path ratio improvement from 63% to 80% with fine-tuning (p<0.001), following 40x103 fine-tuning steps (corresponding to approximately 107 min of clinical inter-hospital transfer time). This work represents a proof of concept for multi-vasculature training and patient-specific adaptation, while further validation is required before clinical deployment.
